Bright Rex 4
4 · Foamix Pharmaceuticals Ltd. · Filed Mar 3, 2020
Insider Transaction Report
Form 4
Bright Rex
Director
Transactions
- Award
Options
2020-02-27+38,156→ 38,156 totalExercise: $3.53Exp: 2030-02-27→ Ordinary Shares (38,156 underlying)
Footnotes (2)
- [F1]Each option represents a contingent right to purchase one ordinary share of the issuer.
- [F2]The ordinary shares underlying this option award vest over a 12 month period, in equal, quarterly installments, ending February 27, 2021.